We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BWX Technologies Q1 Earnings Loom: What Should You Do Now?
Read MoreHide Full Article
Key Takeaways
BWXT has beaten earnings estimates in the last four quarters, with an average surprise of 22.53%.
BWXT's growth is driven by uranium processing and nuclear component manufacturing for U.S. programs.
BWXT faces supply-chain constraints and labor shortages that may impact project timelines and costs.
BWX Technologies, Inc. (BWXT - Free Report) is scheduled to report first-quarter 2026 results on May 4, 2026, after market close.
The Zacks Consensus Estimate for revenues is pegged at $818.6 million, implying 20% growth from the year-ago quarter's reported figure. The consensus estimate for earnings is pegged at 92 cents per share, which indicates an increase of 1.1% from the prior-year number.
Image Source: Zacks Investment Research
BWXT’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 22.53%.
Image Source: Zacks Investment Research
Earnings Whispers
Our proven model predicts an earnings beat for BWXT this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat, which is the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
BWXT has an Earnings ESP of +2.96% and a Zacks Rank of 2 at present.
Some stocks in the same industry that also have the combination of factors indicating an earnings beat are CurtissWright (CW - Free Report) and Huntington Ingalls Industries (HII - Free Report) . CW and HII have an Earnings ESP of +0.72% and +2.69%, respectively. CurtissWright carries a Zacks Rank of 2, while Huntington carries a Zacks Rank of 3 at present.
Key Factors to Consider
Higher uranium processing, down blending operations and manufacturing volume of nuclear components for U.S. government programs are likely to have bolstered the overall top-line performance of BWXT’s Government Operations segment in the first quarter.
Higher revenues related to components manufacturing are expected to have bolstered the top-line performance of its Commercial Operations segment. Contributions from the Kinectrics acquisition are also likely to have boosted this unit’s revenues.
Price Performance & Valuation
BWXT shares have gained 98.1% in the past year, outperforming the 26% growth of the Zacks Aerospace-Defense Equipment industry. It also beat the Zacks Aerospace sector’s growth of 15.3% and the S&P 500’s gain of 33%.
Image Source: Zacks Investment Research
Shares of CurtissWright and Huntington have surged 104.7% and 56.9%, respectively.
BWXT shares are trading at a discount, with its forward 12-month Price/Sales (P/S F12M) being 5.13X compared with its industry’s average of 11.59X.
Image Source: Zacks Investment Research
CW is trading at a P/S F12M of 6.81X, while HII is trading at a P/S F12M of 1.08X.
Investment Thesis
BWXT offers steady near-term visibility supported by its strong backlog and long-term government contracts. As a key supplier to defense and government programs, BWX Technologies benefits from consistent funding. However, its long-term growth will depend on continued demand and government spending, which can change over time.
The company is also expanding into commercial nuclear and medical isotopes, but these businesses are still developing and may take time to grow. There are also risks related to project execution, approvals and higher investments, which could affect margins.
BWXT is facing supply-chain issues and a shortage of skilled workers, which may impact project timelines and costs. Any delays or higher expenses could affect near-term performance, even though long-term demand for nuclear energy and defense remains supportive.
End Note
BWXT is well-positioned for long-term growth, supported by rising revenue and earnings expectations and steady demand for its nuclear components and services across defense and commercial markets.
To conclude, investors interested in BWX Technologies may consider buying the stock before its upcoming earnings release, supported by its strong price performance and favorable earnings outlook. The company’s consistent earnings beats and positive Earnings ESP suggest a good chance of another strong quarter.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
BWX Technologies Q1 Earnings Loom: What Should You Do Now?
Key Takeaways
BWX Technologies, Inc. (BWXT - Free Report) is scheduled to report first-quarter 2026 results on May 4, 2026, after market close.
The Zacks Consensus Estimate for revenues is pegged at $818.6 million, implying 20% growth from the year-ago quarter's reported figure. The consensus estimate for earnings is pegged at 92 cents per share, which indicates an increase of 1.1% from the prior-year number.
Image Source: Zacks Investment Research
BWXT’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 22.53%.
Image Source: Zacks Investment Research
Earnings Whispers
Our proven model predicts an earnings beat for BWXT this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat, which is the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
BWXT has an Earnings ESP of +2.96% and a Zacks Rank of 2 at present.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Other Stocks Worth a Look
Some stocks in the same industry that also have the combination of factors indicating an earnings beat are CurtissWright (CW - Free Report) and Huntington Ingalls Industries (HII - Free Report) . CW and HII have an Earnings ESP of +0.72% and +2.69%, respectively. CurtissWright carries a Zacks Rank of 2, while Huntington carries a Zacks Rank of 3 at present.
Key Factors to Consider
Higher uranium processing, down blending operations and manufacturing volume of nuclear components for U.S. government programs are likely to have bolstered the overall top-line performance of BWXT’s Government Operations segment in the first quarter.
Higher revenues related to components manufacturing are expected to have bolstered the top-line performance of its Commercial Operations segment. Contributions from the Kinectrics acquisition are also likely to have boosted this unit’s revenues.
Price Performance & Valuation
BWXT shares have gained 98.1% in the past year, outperforming the 26% growth of the Zacks Aerospace-Defense Equipment industry. It also beat the Zacks Aerospace sector’s growth of 15.3% and the S&P 500’s gain of 33%.
Image Source: Zacks Investment Research
Shares of CurtissWright and Huntington have surged 104.7% and 56.9%, respectively.
BWXT shares are trading at a discount, with its forward 12-month Price/Sales (P/S F12M) being 5.13X compared with its industry’s average of 11.59X.
Image Source: Zacks Investment Research
CW is trading at a P/S F12M of 6.81X, while HII is trading at a P/S F12M of 1.08X.
Investment Thesis
BWXT offers steady near-term visibility supported by its strong backlog and long-term government contracts. As a key supplier to defense and government programs, BWX Technologies benefits from consistent funding. However, its long-term growth will depend on continued demand and government spending, which can change over time.
The company is also expanding into commercial nuclear and medical isotopes, but these businesses are still developing and may take time to grow. There are also risks related to project execution, approvals and higher investments, which could affect margins.
BWXT is facing supply-chain issues and a shortage of skilled workers, which may impact project timelines and costs. Any delays or higher expenses could affect near-term performance, even though long-term demand for nuclear energy and defense remains supportive.
End Note
BWXT is well-positioned for long-term growth, supported by rising revenue and earnings expectations and steady demand for its nuclear components and services across defense and commercial markets.
To conclude, investors interested in BWX Technologies may consider buying the stock before its upcoming earnings release, supported by its strong price performance and favorable earnings outlook. The company’s consistent earnings beats and positive Earnings ESP suggest a good chance of another strong quarter.